Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-225
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2006
Authors
Publisher
Springer Science and Business Media LLC